Searched over 200M research papers
10 papers analyzed
These studies suggest that signs of lung cancer in women include a higher likelihood of adenocarcinoma, more frequent occurrence in non-smokers, unique biological features, and better response to therapy and survival rates compared to men.
20 papers analyzed
Lung cancer incidence is rising among women, contrasting with a declining trend in men . This increase is partly attributed to smoking, both active and passive, and environmental exposures such as wood smoke . Women are also more likely to develop lung cancer at a younger age compared to men.
Active smoking is a significant risk factor, but passive smoking and exposure to environmental pollutants like wood smoke also contribute substantially to lung cancer cases in women . Interestingly, women have a higher risk of lung cancer at the same smoking levels as men.
Women with lung cancer often present with intraparenchymal opacities and masses, as detected by chest CT scans. Symptoms can include persistent cough, chest pain, and shortness of breath, although these are not exclusive to lung cancer.
Adenocarcinoma is the most common histological type of lung cancer in women, followed by squamous cell carcinoma and small cell carcinoma . This differs from men, where squamous cell carcinoma is more prevalent.
At diagnosis, women are more likely to have extrathoracic metastases compared to men, with common sites including the pleura, bones, brain, and liver . Over half of the cases in women are diagnosed at a metastatic stage.
Hormonal factors, including the presence of estrogen receptors and the impact of sex hormones like 17-β-estradiol, play a role in the pathogenesis of lung cancer in women . These hormonal influences may contribute to differences in tumor biology and clinical outcomes between genders.
Genetic variations and molecular aberrations are more frequently observed in women with lung cancer, potentially due to the carcinogenic effects of tobacco and other environmental factors . These genetic differences necessitate gender-specific approaches in clinical trials and treatment strategies.
Lung cancer in women presents unique epidemiological, clinical, and biological characteristics. The rising incidence, distinct histological types, and significant role of hormonal and genetic factors underscore the need for tailored diagnostic and therapeutic approaches. Understanding these gender-specific differences is crucial for improving outcomes and developing effective prevention strategies for lung cancer in women.
Most relevant research papers on this topic